News & Events

On 23 May, 24 Biotechnology and 27 Computational Biology & Bioinformatics graduates attended the D-BSSE graduation ceremony together with their families and friends, in total some 180 guests. We are especially pleased to have two ETH medallists and three Willi Studer Prize awardees this year. Huge congratulations to all our graduates and best of success for a bright future!

Costanza Borrelli who studied cell-cell interactions during her doctorate in the Moor Lab, and Antonio Jose da Silva Santinha from the Platt Lab, inventor of a novel technology for single-cell CRISPR screening, received the 2024 ETH Medals for their doctoral theses. Big congratulations!

Scientists from Roche's Institute of Human Biology,  their partners at ETH Zurich and Helmholtz Munich, and collaborators have built detailed atlases of brain, gut, and lung organoids to empower future discovery.

On 6 May, D-BSSE again opens a lab to the public: On this guided tour through the Single Cell and Lab Automation Facility you will see how tiny details in cells are visualised using state-of-the-art laser microscopes. By immersing ourselves in the fascinating world of the microcosm, we can unlock the secrets of life. We will also show you how automation is finding its way into the laboratory. Registration is open now!

Congratulations to Prisca Liberali, head of the Multicellular Systems Lab, on receiving the Consolidator Grant of the Swiss National Science Foundation for her research on the self-organisation of multi-cellular systems.

As part of a public event series organised by Treffpunkt Science City, Andreas Moor, head of the Systems Physiology Lab, gave a lecture on liver metastases. Researchers recently discovered how bowel cancer cells dock onto the liver: they detach from the initial tumour, enter the bloodstream and settle in the capillary network of the liver. However, the tumour cells need the support of liver cells to grow into metastases. This finding could enable new therapies to prevent tumour metastases.

The emergence of SARS-CoV-2 variants such as Beta, Gamma, Delta and Omicron is a critical factor for drug development. Researchers around Sai Reddy, head of the Synthetic Immunology lab, now present a computational tool that enables the selection and focused development of lead candidates of antibodies that have the most potential to maintain activity against a rapidly mutating SARS-CoV-2. The deep learning-guided approach identifies antibodies with enhanced resistance to the evolving virus.

A study led by researchers from the group of SNF Ambizione Fellow Nicolas Huguenin-Dezot has found that a protein forms a chain along single-stranded DNA, aiding a bacteriophage in copying its genetic material. Using advanced structural biology, biochemical, and bioinformatics techniques, the team uncovered a previously unknown protein fold binding to DNA in a unique way. This discovery could inspire innovations in medicine and biotechnology.

Not many students find the time to think about founding a startup during the course of their studies. But these six biotechnology students did, during their Master’s at the D-BSSE. They discovered that they had in common an entrepreneurial spirit and, fascinated by the potential of enzymes, they developed the business idea that led to the startup Hephaistos. Here, Jannik Neumann, Lucas Merlicek, Moritz Ullhofen, Ilya Schneider, Lukas Radtke and Arthur Theuer talk about their exciting journey.